Profil
Bruno Besse is currently the Chief Medical Officer at Quantum Genomics SA. He previously worked as a Principal at Roche Diagnostics GmbH, Head-Medical Affairs at Crossject SA, and Principal at Aventis Pharma SARL. Dr. Besse completed his undergraduate degree at INSEAD and holds a doctorate from Université de Paris XI Paris Sud.
Postes actifs de Bruno Besse
| Sociétés | Poste | Début |
|---|---|---|
| QUANTUM GENOMICS | Directeur Technique/Scientifique/R&D | 01/03/2017 |
Anciens postes connus de Bruno Besse
| Sociétés | Poste | Fin |
|---|---|---|
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Corporate Officer/Principal | - |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
| CROSSJECT | Directeur Technique/Scientifique/R&D | - |
Formation de Bruno Besse
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Commercial Services |
Crossject SA
Crossject SA Medical SpecialtiesHealth Technology Designs and develops needle free, pre-filled single-use injection systems | Health Technology |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris XI Paris Sud
Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quantum Genomics SA
Quantum Genomics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cardiovascular diseases | Health Technology |
















